+

PE20040606A1 - 4-amino-1-(piridilmetil)piperidina sustituida y compuestos relacionados - Google Patents

4-amino-1-(piridilmetil)piperidina sustituida y compuestos relacionados

Info

Publication number
PE20040606A1
PE20040606A1 PE2003001087A PE2003001087A PE20040606A1 PE 20040606 A1 PE20040606 A1 PE 20040606A1 PE 2003001087 A PE2003001087 A PE 2003001087A PE 2003001087 A PE2003001087 A PE 2003001087A PE 20040606 A1 PE20040606 A1 PE 20040606A1
Authority
PE
Peru
Prior art keywords
alkyl
alkinyl
cycloalkyl
alkenyl
piperidine
Prior art date
Application number
PE2003001087A
Other languages
English (en)
Inventor
Trevor Mischki
Mathai Mammen
Craig Husfeld
Sarah Dunham
Li Li
Ioanna Stergiades
Yu-Hua Ji
Yan Chen
Adam Hughes
Richard Wilson
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of PE20040606A1 publication Critical patent/PE20040606A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA (I) DONDE W, X, Y y Z SON INDEPENDIENTEMENTE CH, CR4, N Y N--0, CON LA CONDICION DE QUE AL MENOS UNO Y NO MAS DE DOS SEA N O N--O, R1 ES UN -(CH2)a-(O)b-(CH2)c-; R2 ES H, ALQUILO(C1-C6), ALQUENILO O ALQUINILO(C2-C6), CICLOALQUILO(C3-C6), CH2R5 Y (CH2)xR6, OPCIONALMENTE SUSTITUIDOS POR FLUOR; R3 ES H, ALQUILO(C1-C6), ALQUENILO O ALQUINILO(C2-C6), CICLOALQUILO(C3-C6), CH2R7 Y (CH2)yR8, OPCIONALMENTE SUSTITUIDOS POR FLUOR; Ra Y Rb SON INDEPENDIENTEMENTE ALQUILO(C1-C4), ALQUENILO O ALQUINILO(C2-C4), CICLOALQUILO(C3-C6), CIANO, HALO, ORf, SRf, S(O)Rf Y NRgRh, O DOS GRUPOS Ra O Rb ADYACENTES; Rc Y Rd SON INDEPENDIENTEMENTE ALQUILO(C1-C4) Y FLUOR; Re ES H, ALQUILO(C1-C6), ALQUENILO O ALQUINILO(C2-C6), CICLOALQUILO(C3-C6), ENTRE OTROS O AMBOS Re SE UNEN JUNTO CON EL N FORMANDO UN HETEROCICLO(C3-C6), OPCIONALMENTE SUSTITUIDOS, SON COMPUESTOS PREFERIDOS: 4-{N-[7-(3-(S)-1-CARBAMOIL-1,1-DIFENILMETIL)PIRROLIDIN-1-IL)HEPT-1-IL]-N-(ISOPROPIL)AMINO}-1-(4-METOXIPIRID-3-ILMETIL)PIPERIDINA, 4-{N-[7-(3-(S)-1-CARBAMOIL-1,1-DIFENILMETIL)PIRROLIDIN-1-IL)HEPT-1-IL]-N-(ETIL)AMINO}-1-(2-METOXIPIRIDIN-3-ILMETIL)PIPERIDINA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCESO DE ELABORACION. ESTOS COMPUESTOS Y SUS INTERMEDIOS SON INHIBIDORES SELECTIVOS DEL RECEPTOR DEL SUBTIPO M2 Y SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR RECEPTORES MUSCARINICOS COMO VEJIGA SUPERACTIVA, SINDROME DE INTESTINOS IRRITABLES, ASMA Y ENFERMEDAD OBSTRUCTIVA CRONICA
PE2003001087A 2002-10-30 2003-10-28 4-amino-1-(piridilmetil)piperidina sustituida y compuestos relacionados PE20040606A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42222902P 2002-10-30 2002-10-30
US48648303P 2003-07-11 2003-07-11

Publications (1)

Publication Number Publication Date
PE20040606A1 true PE20040606A1 (es) 2004-09-08

Family

ID=32314442

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003001087A PE20040606A1 (es) 2002-10-30 2003-10-28 4-amino-1-(piridilmetil)piperidina sustituida y compuestos relacionados

Country Status (20)

Country Link
US (2) US7285564B2 (es)
EP (1) EP1556372B1 (es)
JP (2) JP4448492B2 (es)
KR (1) KR20050061504A (es)
AR (1) AR041855A1 (es)
AT (1) ATE363482T1 (es)
AU (1) AU2003285100A1 (es)
BR (1) BR0315778A (es)
CA (1) CA2500800A1 (es)
DE (1) DE60314170T2 (es)
EC (1) ECSP055762A (es)
ES (1) ES2287543T3 (es)
IS (1) IS7780A (es)
MX (1) MXPA05004507A (es)
NO (1) NO20052521L (es)
PE (1) PE20040606A1 (es)
PL (1) PL376716A1 (es)
RU (1) RU2005116239A (es)
TW (2) TWI295669B (es)
WO (1) WO2004041806A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI295669B (en) * 2002-10-30 2008-04-11 Theravance Inc Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
TW200510298A (en) * 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
PE20050973A1 (es) * 2003-10-29 2005-11-19 Theravance Inc Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos
EP1725525A1 (en) * 2004-03-11 2006-11-29 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
WO2005087763A1 (en) * 2004-03-11 2005-09-22 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
TW200540154A (en) * 2004-06-10 2005-12-16 Theravance Inc Crystalline form of a substituted pyrrolidine compound
TW200628465A (en) * 2004-10-28 2006-08-16 Theravance Inc Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
WO2006058294A2 (en) * 2004-11-29 2006-06-01 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP1863490A2 (en) * 2005-03-28 2007-12-12 Vertex Pharmaceuticals Incorporated Muscarinic modulators
WO2008103426A1 (en) * 2007-02-23 2008-08-28 Theravance, Inc. Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
WO2009153649A1 (en) * 2008-06-19 2009-12-23 Medichem, S.A. Process for preparing 3-substituted pyrrolidine compounds
IN2012DN02782A (es) * 2009-10-07 2015-09-18 Merck Sharp & Dohme
WO2011143457A2 (en) 2010-05-12 2011-11-17 Northwestern University Compositions and methods for treating or preventing atrial fibrillation
US9522129B2 (en) 2010-08-03 2016-12-20 Velicept Therapeutics, Inc. Pharmaceutical Combination
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
KR20180008918A (ko) * 2010-08-03 2018-01-24 앨씨알엑스, 인크. 과민성 방광 치료를 위한 베타-3 아드레날린 수용체 작용제 및 무스카린 수용체 길항제의 약학적 배합제
SG11201404776PA (en) * 2012-02-09 2014-09-26 Altherx Inc Combination of muscarinic receptor antagonists and beta- 3 adrenoceptor agonists for treating overactive bladder
CN107205964A (zh) 2014-12-03 2017-09-26 威力塞帕特治疗股份有限公司 使用调节释放索拉贝隆用于下尿路症状的组合物和方法
PT3365321T (pt) 2015-10-23 2024-01-12 B3Ar Therapeutics Inc Zwiterião de solabegron e suas utilizações

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192221A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones and production thereof
US3192206A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-aminoalkyl)-3, 3-disubstitutedn-hydrocarbon-2-pyrrolidinones and corresponding-2-thionpyrrolidinones
US3192210A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones
GB1507462A (en) 1974-03-21 1978-04-12 Gallardo Antonio Sa N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
GB1593851A (en) 1976-10-27 1981-07-22 Gallardo Antonio Sa N-(4-piperidyl)-benzamides and pharmaceutical compositions containing them
US4002766A (en) * 1974-12-26 1977-01-11 A. H. Robins Company, Incorporated Antiarrhythmia methods
US3984557A (en) * 1974-12-26 1976-10-05 A. H. Robins Company, Incorporated Antiarrhythmia compositions and methods
GB1575310A (en) 1976-11-16 1980-09-17 Anphar Sa Piperidine derivatives
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives
CH628885A5 (en) 1978-01-01 1982-03-31 Anphar Sa Piperidine derivative
US4594343A (en) * 1984-10-19 1986-06-10 Shanklin Jr James R 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
IL76583A (en) 1984-10-19 1988-08-31 Robins Co Inc A H 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them
EP0228893A3 (en) 1985-12-20 1990-01-03 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment
US4810713A (en) * 1985-12-20 1989-03-07 A. H. Robins Company, Incorporated Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment
US5932594A (en) * 1988-11-01 1999-08-03 Pfizer, Inc. Muscarinic receptor antagonists
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
US5233053A (en) * 1989-03-17 1993-08-03 Pfizer Inc. Pyrrolidine derivatives
US5070087A (en) * 1989-05-08 1991-12-03 A. H. Robins Company, Incorporated Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents
US5028616A (en) * 1989-09-05 1991-07-02 G. D. Searle & Co. N-benzylpiperidine amides
US5281601A (en) * 1989-12-12 1994-01-25 Pfizer Inc. Muscarinic receptor antagonists
GB8928042D0 (en) 1989-12-12 1990-02-14 Pfizer Ltd Muscarinic receptor antagonists
US5607950A (en) * 1990-01-06 1997-03-04 Pfizer Inc. Muscarinic receptor antagonists
GB9000301D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Piperidine & pyrrolidine derivatives
US5486527A (en) * 1990-01-06 1996-01-23 Pfizer Inc. Anticholinergic agents
DE69632728T2 (de) * 1995-04-28 2004-10-14 Banyu Pharmaceutical Co., Ltd. 1,4-disubstituierte piperidinderivate
AU7145996A (en) * 1995-10-13 1997-04-30 Banyu Pharmaceutical Co., Ltd. Substituted heteroaromatic derivatives
PE92198A1 (es) 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
CA2296329A1 (en) 1997-07-24 1999-02-04 Masakazu Nakano Aminocycloalkane compounds
AU9094598A (en) 1997-09-18 1999-04-05 Mitsubishi-Tokyo Pharmaceuticals, Inc. Imidazoline compounds
US6319920B1 (en) * 1998-02-27 2001-11-20 Syntex (U.S.A.) Llc 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives
NZ505329A (en) 1998-06-08 2003-05-30 Theravance Inc Two heteroaryl or aryl containing compounds covalently attached via a linker useful as muscarinic receptor antagonists
US6693202B1 (en) * 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
UA73543C2 (uk) * 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
DE60021282T2 (de) * 1999-12-07 2006-05-18 Theravance, Inc., South San Francisco Carbamat-derivate als muscarin-rezeptor antonisten
KR100869722B1 (ko) 2000-12-22 2008-11-21 알미랄 에이쥐 퀴누클리딘 카르바메이트 유도체 및 ｍ3 길항제로서 그의사용
NZ526674A (en) 2000-12-28 2005-03-24 Almirall Prodesfarma Ag Novel quinuclidine derivatives and medicinal compositions containing the same
BR0214674A (pt) 2001-12-03 2004-10-19 Hoffmann La Roche Derivados 4-piperdinil alquilamina como antagonistas do receptor muscarìnico
TWI295669B (en) 2002-10-30 2008-04-11 Theravance Inc Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
JP4767842B2 (ja) 2003-04-01 2011-09-07 セラヴァンス， インコーポレーテッド β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物
TW200510298A (en) 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
PE20050973A1 (es) 2003-10-29 2005-11-19 Theravance Inc Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos
EP1725525A1 (en) 2004-03-11 2006-11-29 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
WO2005087763A1 (en) 2004-03-11 2005-09-22 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
TW200540154A (en) 2004-06-10 2005-12-16 Theravance Inc Crystalline form of a substituted pyrrolidine compound
TW200628465A (en) 2004-10-28 2006-08-16 Theravance Inc Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds

Also Published As

Publication number Publication date
US7285564B2 (en) 2007-10-23
BR0315778A (pt) 2005-09-06
PL376716A1 (pl) 2006-01-09
MXPA05004507A (es) 2005-10-18
AU2003285100A1 (en) 2004-06-07
WO2004041806A2 (en) 2004-05-21
IS7780A (is) 2005-03-31
TW200800953A (en) 2008-01-01
JP2010059214A (ja) 2010-03-18
US20040122014A1 (en) 2004-06-24
ECSP055762A (es) 2005-07-06
JP2006512408A (ja) 2006-04-13
EP1556372B1 (en) 2007-05-30
DE60314170T2 (de) 2008-01-24
EP1556372A2 (en) 2005-07-27
US8030502B2 (en) 2011-10-04
AR041855A1 (es) 2005-06-01
KR20050061504A (ko) 2005-06-22
WO2004041806A3 (en) 2004-08-05
RU2005116239A (ru) 2006-01-27
US20080091034A1 (en) 2008-04-17
TW200418833A (en) 2004-10-01
CA2500800A1 (en) 2004-05-21
ES2287543T3 (es) 2007-12-16
NO20052521L (no) 2005-05-25
ATE363482T1 (de) 2007-06-15
JP4448492B2 (ja) 2010-04-07
TWI295669B (en) 2008-04-11
DE60314170D1 (de) 2007-07-12

Similar Documents

Publication Publication Date Title
PE20040606A1 (es) 4-amino-1-(piridilmetil)piperidina sustituida y compuestos relacionados
PE20060363A1 (es) DERIVADOS DE TETRAAZABENZO[e]AZULENO Y SUS ANALOGOS
MX2022014312A (es) Inhibidores de sarcomero cardiaco.
PE20011371A1 (es) Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5
PE20080843A1 (es) Inhibidores de renina y metodo para su utilizacion
CR8505A (es) Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad
PE20061451A1 (es) Compuestos derivados de diarilsulfona sulfonamidas
PE20081545A1 (es) Derivados de sulfonamida como inhibidores de acido graso sintasas
PE20060361A1 (es) Compuestos heterociclicos como inhibidores de la cinesina mitotica
NO20091551L (no) Derivater av 4-(2-amino-1-hydroksyetyl)fenyl som agonister for betta-2 adrenergisk reseptor
EA200600348A1 (ru) Новые соединения
KR20030059139A (ko) 신규한 아미드 유도체 및 그의 의약적 용도
AR074352A1 (es) Acidos naftalen-2-il-aceticos sustituidos, composiciones farmaceuticas que los contienen, y uso de los mismos en el tratamiento de enfermedades alergicas,tales como rinitis, asma y dermatitis atopica.
JP2002504081A (ja) エンドセリン拮抗物質としての新規なベンゾ―１，３―ジオキソリル―及びベンゾフラニル置換ピロリジン誘導体
PE20051054A1 (es) Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento
PE20140968A1 (es) Derivados de benzamida sustituida
EA200702612A1 (ru) Соединения бензимидазолкарбоксамида в качестве агонистов рецепторов 5-нт
JP2020525490A (ja) ヘテロアリールジヒドロピリミジン誘導体及びｂ型肝炎感染を治療する方法
ATE505462T1 (de) Neue biologischaktive molekü le
DE60317333D1 (de) Tetracyklische arylsulfonylindole mit affinität zum serotonin rezeptor
MXPA05009660A (es) Derivados azabiciclicos de piridiloximetilo y bencisoxazol.
PE20250558A1 (es) Compuestos, procedimiento de obtencion de los compuestos, composicion farmaceutica, uso de los compuestos y metodo de tratamiento de desordenes psiquiatricos y/o trastornos del sueno
NO20060258L (no) Nematicidale tiazolin-inneholdende fluorobutener
NO20063562L (no) Fusjonerte heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
PE20060770A1 (es) Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1

Legal Events

Date Code Title Description
FC Refusal
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载